相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Advanced Hydrogel systems for mandibular reconstruction
Jiaxin Guo et al.
BIOACTIVE MATERIALS (2023)
American Association of Oral and Maxillofacial Surgeons' Position Paper on Medication-Related Osteonecrosis of the Jaws-2022 Update
Salvatore L. Ruggiero et al.
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2022)
Tooth extractions in patients with cancer receiving high-dose antiresorptive medication: a randomized clinical feasibility trial of drug holiday versus drug continuation
Camilla Ottesen et al.
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY (2022)
Antiresorptive-Type and Discontinuation-Timing Affect ONJ Burden
D. Hadaya et al.
JOURNAL OF DENTAL RESEARCH (2021)
Local administration of zoledronic acid prevents traumatic osteonecrosis of the femoral head in rat model
Jun Zhao et al.
JOURNAL OF ORTHOPAEDIC TRANSLATION (2021)
Drug holiday clinical relevance verification for antiresorptive agents in medication-related osteonecrosis cases of the jaw
Saki Hayashida et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2020)
The efficacy and safety of denosumab in postmenopausal women with osteoporosis previously treated with bisphosphonates: A review
Yilin Zhu et al.
JOURNAL OF ORTHOPAEDIC TRANSLATION (2020)
Alendronate or Zoledronic acid do not impair wound healing after tooth extraction in postmenopausal women with osteoporosis
Philippe Lesclous et al.
BONE (2020)
Dynamic polarization shifting from M1 to M2 macrophages in reduced osteonecrosis of the jaw-like lesions by cessation of anti-RANKL antibody in mice
Saki Tamaki et al.
BONE (2020)
A Drug Holiday Reduces the Frequency and Severity of Medication-Related Osteonecrosis of the Jaw in a Minipig Model
Sven Otto et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2020)
Efficacy of a high-dose antiresorptive drug holiday to reduce the risk of medication-related osteonecrosis of the jaw (MRONJ): A systematic review
Camilla Ottesen et al.
HELIYON (2020)
Drug holiday patterns and bisphosphonate-related osteonecrosis of the jaw
Sun-Young Jung et al.
ORAL DISEASES (2019)
Value of pre-operative CTX serum levels in the prediction of medication-related osteonecrosis of the jaw (MRONJ): a retrospective clinical study
Martin Salgueiro et al.
EPMA JOURNAL (2019)
Medication-related osteonecrosis of the jaw-like lesions in rodents: A comprehensive systematic review and meta-analysis
Shinichiro Kuroshima et al.
GERODONTOLOGY (2019)
Medication-related osteonecrosis of the jaw after tooth extraction in cancer patients: a multicenter retrospective study
T. Hasegawa et al.
OSTEOPOROSIS INTERNATIONAL (2019)
Antiresorptive Agent-Related Osteonecrosis of the Jaw (ARONJ): A Twist of Fate in the Bone
Takahiko Shibahara
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2019)
Medication-related osteonecrosis of the jaw: Prevention, diagnosis and management in patients with cancer and bone metastases
Sven Otto et al.
CANCER TREATMENT REVIEWS (2018)
The risk of osteonecrosis on alveolar healing after tooth extraction and systemic administration of antiresorptive drugs in rodents: a systematic review
Victor Lousan do Nascimento Poubel et al.
JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY (2018)
Case-aced Review of Osteonecrosis of the Jaw (ONJ) and Application of the International Recommendations for Management From the International Task Force on ONJ
Aliya A. Khan et al.
JOURNAL OF CLINICAL DENSITOMETRY (2017)
Effectiveness of treatments for medication-related osteonecrosis of the jaw A systematic review and meta-analysis
Mohamed El-Rabbany et al.
JOURNAL OF THE AMERICAN DENTAL ASSOCIATION (2017)
A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ?
T. Hasegawa et al.
OSTEOPOROSIS INTERNATIONAL (2017)
Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer
Alison T. Stopeck et al.
SUPPORTIVE CARE IN CANCER (2016)
Lack of cooperation between physicians and dentists during osteoporosis treatment may increase fractures and osteonecrosis of the jaw
Akira Taguchi et al.
CURRENT MEDICAL RESEARCH AND OPINION (2016)
Main differences in osteoporotic fracture models: which should I use?
A. Hamish Simpson et al.
INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED (2016)
Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research
Robert A. Adler et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2016)
Postmenopausal Osteoporosis
Dennis M. Black et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Animal model for medication-related osteonecrosis of the jaw with precedent metabolic bone disease
Jin-Woo Kim et al.
BONE (2015)
Impact of Osteonecrosis of the Jaw on Osteoporosis Treatment in Japan: Results of a Questionnaire-Based Survey by the Adequate Treatment of Osteoporosis (A-TOP) Research Group
Akira Taguchi et al.
CALCIFIED TISSUE INTERNATIONAL (2015)
Animal models for osteoporosis
Toshihisa Komori
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
OPG-Fc but Not Zoledronic Acid Discontinuation Reverses Osteonecrosis of the Jaws (ONJ) in Mice
Rafael Scaf de Molon et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2015)
Perioperative discontinuation of intravenous bisphosphonate therapy reduces the incidence and severity of bisphosphonate-related osteonecrosis of the jaw: A randomized, controlled, prospective experimental study in rats
Mohammad Zandi et al.
JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY (2015)
Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International Consensus
Aliya A. Khan et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2015)
A Model for Osteonecrosis of the Jaw with Zoledronate Treatment following Repeated Major Trauma
R. Nicole Howie et al.
PLOS ONE (2015)
Effect of antiresorptive drugs on bony turnover in the jaw: denosumab compared with bisphosphonates
Oliver Ristow et al.
BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY (2014)
American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw-2014 Update
Salvatore L. Ruggiero et al.
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2014)
Prevention and treatment of postmenopausal osteoporosis
Sri Harsha Tella et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2014)
Drug holiday as a prognostic factor of medication-related osteonecrosis of the jaw
Yoon Ho Kim et al.
JOURNAL OF THE KOREAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS (2014)
American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Postmenopausal Osteoporosis: Executive Summary of Recommendations
Nelson Watts et al.
Endocrine Practice (2013)
Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study
Sant Chawla et al.
LANCET ONCOLOGY (2013)
Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013
J. Compston et al.
MATURITAS (2013)
Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases
F. Saad et al.
ANNALS OF ONCOLOGY (2012)
Factors influencing surgical treatment of bisphosphonate-related osteonecrosis of the jaws
Arno Wutzl et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2012)
Epidemiology and pathogenesis of osteonecrosis of the jaw
Ian R. Reid et al.
NATURE REVIEWS RHEUMATOLOGY (2012)
Antiresorptives and Osteonecrosis of the Jaw
Junro Yamashita et al.
Journal of Evidence-Based Dental Practice (2012)
Potential pathophysiological mechanisms in osteonecrosis of the jaw
Regina Landesberg et al.
BISPHOSPHONATES AND OSTEONECROSIS OF THE JAW (2011)
Denosumab and bisphosphonates: Different mechanisms of action and effects
Roland Baron et al.
BONE (2011)
Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma
David H. Henry et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Osteonecrosis of the Jaw and the Role of Macrophages
Michael Pazianas
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
Alison T. Stopeck et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
The incidence of osteonecrosis of the jaw in patients receiving 5 milligrams of zoledronic acid Data from the Health Outcomes and Reduced Incidence With Zoledronic Acid Once Yearly clinical trials program
John T. Grbic et al.
JOURNAL OF THE AMERICAN DENTAL ASSOCIATION (2010)
Bisphosphonate-associated osteonecrosis of the jaw: A key role of inflammation?
Philippe Lesclous et al.
BONE (2009)
The Pathogenesis of Bisphosphonate-Related Osteonecrosis of the Jaw: So Many Hypotheses, So Few Data
Matthew R. Allen et al.
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2009)
Risk of hip fracture after bisphosphonate discontinuation: implications for a drug holiday
J. R. Curtis et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Oral bisphosphonate-induced osteonecrosis: Risk factors, prediction of risk using serum CTX testing, prevention, and treatment
Robert E. Marx et al.
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2007)
Microcrack frequency and bone remodeling in postmenopausal osteoporotic women on long-term bisphosphonates: A bone biopsy study
Roland D. Chapurlat et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Bisphosphonate-induced avascular osteonecrosis of the jaws: a clinical report of 11 cases
I. Dimitrakopoulos et al.
INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2006)
Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: Risk factors, recognition, prevention, and treatment
RE Marx et al.
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2005)
Pharmacokinetic considerations in determining the terminal elimination half-lives of bisphosphonates
KC Lasseter et al.
CLINICAL DRUG INVESTIGATION (2005)
分享论文
